Inspections emerge as flashpoint in BsUFA II assessment meeting
Regulatory NewsMichael Mezher
Audit/inspectionBiologics/ biosimilars/ vaccinesHealth Authority meeting and communication strategyNorth AmericaProduct LifecycleRegulatory NewsMichael MezherAudit/inspectionBiologics/ biosimilars/ vaccinesHealth Authority meeting and communication strategyNorth AmericaProduct Lifecycle